Philip Hampton is being lined up to replace Sir Christopher Gent as GSK’s next chairman
Sir Philip Hampton is being lined up to take the role of chairman at Britain’s biggest drug company Glaxosmithkline after exiting Royal Bank of Scotland, Sky News reports.
It’s said that Hampton will join GSK as early as next month as a non-executive director or deputy chairman, moving into the chairman’s seat by 2015.
GSK’s current chairman Christopher Gent has previously stated his intention to announce a successor this year with a view to standing down next year after a decade in charge.
Hampton was parachuted into the bailed-out bank in 2009 in to help turn it around and was previously chairman of Sainsbury’s. Hampton has also been finance director at some of the UK’s leading firms, including BT, Lloyds bank and British Gas.
RBS declined to comment and GSK declined to comment.
Update: This story was updated to say that GSK declined to comment.